title: A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Barosi
authors.forename: Gunnar
authors.initials: G
authors.lastname: Birgegard
authors.forename: Guido
authors.initials: G
authors.lastname: Finazzi
authors.forename: Martin
authors.initials: M
authors.lastname: Griesshammer
authors.forename: Claire
authors.initials: C
authors.lastname: Harrison
authors.forename: Hans
authors.initials: H
authors.lastname: Hasselbalch
authors.forename: Jean-Jacques
authors.initials: JJ
authors.lastname: Kiladijan
authors.forename: Eva
authors.initials: E
authors.lastname: Lengfelder
authors.forename: Ruben
authors.initials: R
authors.lastname: Mesa
authors.forename: Mary F
authors.initials: MF
authors.lastname: Mc Mullin
authors.forename: Francesco
authors.initials: F
authors.lastname: Passamonti
authors.forename: John T
authors.initials: JT
authors.lastname: Reilly
authors.forename: Alessandro M
authors.initials: AM
authors.lastname: Vannucchi
authors.forename: Tiziano
authors.initials: T
authors.lastname: Barbui
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003245:Consensus Statements as Topic; D004351:Drug Resistance; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D011087:Polycythemia Vera / Q000188:drug therapy*; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D009626:Terminology as Topic
chemical_list: D000970:Antineoplastic Agents; D006918:Hydroxyurea